ismp-hosp-temp-MASTER.qxd

First Page		Document Content
Date: 2012-05-23 13:20:07 Pharmaceutical sciences Drug paraphernalia Syringe Pharmaceutical drug Hypodermic needle Medical prescription Dosing Pharmacy Drug Medicine Medical equipment Pharmacology		ismp-hosp-temp-MASTER.qxd Add to Reading List Source URL: www.consumermedsafety.org Download Document from Source Website File Size: 440,08 KB Share Document on Facebook

	Microsoft Word - VIS410 Phase 2a Trial Dosing Release FINAL DocID: 1veWX - View Document
	Voluntary Recall: Lorazepam Oral Concentrate, USP 2mg/ml by Amneal Pharmaceuticals - Misprinted Dosing Droppers At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform DocID: 1vbgN - View Document
	Methadone Dosing Guideline DocID: 1v2ad - View Document
	Initial Data from a Phase 2 Multiple Ascending Dose Clinical Trial of SEL-212: Monthly Dosing of SEL-212 Mitigates the Formation of Anti-Drug Antibodies and Enables Sustained Control of Serum Uric Acid in Symptomatic Gou DocID: 1uVOT - View Document
	Phase 2 Clinical Data of SEL-212 in Symptomatic Gout Patients: Monthly Dosing of a Pegylated Uricase (Pegsiticase) with SVPRapamycin Enables Sustained Reduction of Serum Uric Acid Levels by Mitigating Formation of Anti-D DocID: 1uNq4 - View Document